The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients
出版年份 2017 全文链接
标题
The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-01-09
DOI
10.1038/srep40210
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Effects of Oseltamivir, Zanamivir, Laninamivir and Peramivir on Seasonal Influenza Infection in Outpatients in Japan during the Winter of 2012-2013
- (2017) Yuji Takemoto et al. CHEMOTHERAPY
- Competitive exclusion in a multi-strain immuno-epidemiological influenza model with environmental transmission
- (2016) Yan-Xia Dang et al. Journal of Biological Dynamics
- Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study
- (2015) Yan Zhang et al. BMC INFECTIOUS DISEASES
- Determining drug efficacy parameters for mathematical models of influenza
- (2015) Noah F. Beggs et al. Journal of Biological Dynamics
- Characterization of Drug-Resistant Influenza Virus A(H1N1) and A(H3N2) Variants SelectedIn Vitrowith Laninamivir
- (2014) Mélanie Samson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor
- (2014) Norio Sugaya et al. ANTIVIRAL THERAPY
- Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials
- (2014) Richard Whitley et al. ANTIVIRAL THERAPY
- Sequential Influenza B Viral Load and Susceptibility in Children Treated With Oseltamivir and Zanamivir
- (2014) Masatoki Sato et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors
- (2012) Margaret Okomo-Adhiambo et al. Influenza and Other Respiratory Viruses
- The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets
- (2012) L. T. Pinilla et al. JOURNAL OF VIROLOGY
- Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture
- (2011) Benjamin P Holder et al. BMC PUBLIC HEALTH
- Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008
- (2011) Katja Bauer et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model
- (2011) Benjamin P. Holder et al. PLoS One
- Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus
- (2011) Justin D. Hoopes et al. PLoS One
- Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays
- (2010) H. T. Nguyen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza
- (2010) Nicolas Widmer et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
- (2010) B. E. Davies JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons
- (2010) Naoki Kawai et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study
- (2010) Hana M. Dobrovolny et al. JOURNAL OF THEORETICAL BIOLOGY
- Antiviral Prescriptions to U.S. Ambulatory Care Visits with a Diagnosis of Influenza before and after High Level of Adamantane Resistance 2005–06 Season
- (2010) Yu-Hsiang Hsieh et al. PLoS One
- Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
- (2009) J. T. Nguyen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Evolution of Influenza Resistance and Treatment
- (2009) David M. Weinstock JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An accurate two-phase approximate solution to an acute viral infection model
- (2009) Amber M. Smith et al. JOURNAL OF MATHEMATICAL BIOLOGY
- Mixed Infection and the Genesis of Influenza Virus Diversity
- (2009) E. Ghedin et al. JOURNAL OF VIROLOGY
- Sensitivity of H5N1 influenza viruses to oseltamivir: an update
- (2008) Marie-Anne Rameix-Welti et al. Future Virology
- Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid
- (2008) Craig R. Rayner et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Modeling amantadine treatment of influenza A virus in vitro
- (2008) Catherine A.A. Beauchemin et al. JOURNAL OF THEORETICAL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started